| Identification | |
| Name: | 1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, hydrochloride (1:2) |
| Synonyms: | 1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, dihydrochloride (9CI); |
| CAS: | 212141-51-0 |
| Molecular Formula: | C20H15ClN4.2(HCl) |
| Molecular Weight: | 419.74 |
| InChI: | InChI=1/C20H15ClN4.2ClH/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14;;/h1-12H,13H2,(H,23,25);2*1H |
| Molecular Structure: |  |
| Properties | |
| Appearance: | White to Off-White Crystalline Powder |
| Specification: |
1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, hydrochloride (1:2) , its cas register number 212141-51-0. It also can be called CGP-79787 Dihydrochlorid ; N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine Dihydrochloride ; Vatalanib Dihydrochloride ; and CGP-79787 Dihydrochloride . |
| Usage: |
1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, hydrochloride (1:2) (CAS NO.212141-51-0) can be used as Vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. It also can be used as Antineoplastic. |
| Safety Data | |
 |
|
